About Mikael Sodergren
Dr Mikael Sodergren MBChB(Hons) DIC PhD FRCS, is a Clinical Senior Lecturer at Imperial College London where he leads the Medical Cannabis Research Group. He is co-founder of Sapphire Medical Clinics, the first medical cannabis clinic approved by the CQC in England, and Chief Medical Officer at Curaleaf International.
Timestamps
-
0:00 Welcome to The Cannabis Conversation
-
1:08 Introduction to Dr. Mikael Sodergren and his clinical work as a surgeon within oncology
-
3:48 Dr. Sodergren’s initial research into the use of CBD in cancer treatment and interest in medical cannabis
-
5:43 Dr. Sodergren’s current research into pain pathways and the use of cannabis to combat acute and chronic pain
-
7:57 Imperial College London and its progressive research within cannabis (and psychedelic)
-
09:35 Have you ever encountered any stigma from peers or colleagues?
-
11:02 The founding of Sapphire Medical Clinics
-
13:30 How does the process of clinical research work?
-
18:12 How are regulators involved in the process?
-
19:04 Preclinical research and what is involved
-
20:21 What challenges are involved with cannabis drug development?
-
26:33 Randomised controlled trials and their use within medical cannabis development
-
29:59 Clinical trials vs. real world evidence
-
31:48 How do you feel about the use of cannabis flower as a medicine?
-
33:33 What factors can help accelerate medical cannabis research?
Resources
Sapphire Medical Clinics’ Website: https://www.sapphireclinics.com/
Follow Sapphire Medical Clinics on LinkedIn: https://www.linkedin.com/company/sapphire-medical-clinics/
More about the Medical Cannabis Research Group at Imperial College London:
https://www.imperial.ac.uk/department-surgery-cancer/research/surgery/groups/medical-cannabis-research-group/